Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.6.2024Johnson & Johnson, s.r.o. (JHN-SK-1)49926Concerta 54 mg tablety s predĺženým uvoľňovaním (tbl plg 30x54 mg (fľ.HDPE))20.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)18668GYRABLOCK 400 mg (tbl flm 30x400 mg (fľ.PE))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)2834BMANTOMED 10 mg (tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)2849BMANTOMED 20 mg (tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)40200KLERIMED 250 mg (tbl flm 14x250 mg (blis.PVC/PVDC/Al))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)4784BAKTIPROL 400 mg tablety (tbl 60x400 mg (blis.PVC/PVDC/Al))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))17.6.2024O
 20.6.2024MEDOCHEMIE Ltd. (MOE)53504RAMIMED 10 mg (tbl 30x10 mg (blis.Al/Al/PA/PVC))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)59188BETAC (tbl flm 30x20 mg (blister PVC/Al))17.6.2024O
 20.6.2024MEDOCHEMIE Ltd. (MOE)59193BETAC (tbl flm 100x20 mg (blister PVC/Al))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)6341ASULCEF 2 g (plo ijf 10x2 g (liek.inj.skl.))17.6.2024O
 20.6.2024MEDOCHEMIE Ltd. (MOE)64831AXETINE 1,5 g (plo jof 10x1,5 g (liek.inj.skl.))17.6.2024O
 20.6.2024MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)6625DMEDOVIR 250 mg prášok na infúzny roztok (plv ifo 5x250 mg (liek.inj.skl.))17.6.2024R
 20.6.2024MEDOCHEMIE Ltd. (MOE)67016AXETINE 750 mg (plo jof 10x750 mg (liek.inj.skl.))17.6.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)